Emmes Group Earns ISO 27001:2022 Certification for Data Security
12 Feb 2025 //
CONTRACTPHARMA
Emmes Group Appoints Chief Commercial Officer of Emmes Biopharma
16 Jan 2025 //
CONTRACTPHARMA
Emmes Awarded Multi-Task IDIQ Contract
01 Oct 2024 //
CONTRACT PHARMA
Emmes Awarded $50M Contract to Support NIDA`s Clinical Trials Network
04 Sep 2024 //
PR NEWSWIRE
Emmes Acquires VaxTRIALS
05 Oct 2023 //
PR NEWSWIRE
Emmes calls in telehealth capabilities for eClinical platform
28 Sep 2023 //
FIERCE BIOTECH
Emmes Appoints Peter Ronco as Chief Executive Officer
20 Sep 2023 //
BUSINESSWIRE
Kristin Judge Joins Emmes as Chief Growth Officer
25 May 2023 //
PR NEWSWIRE
Emmes Acquires Essex Management
22 Mar 2023 //
CONTRACT PHARMA
Emmes Opens New Office in Wilmington, NC
21 Feb 2023 //
CONTRACT PHARMA
Emmes Opens New Office in Wilmington, North Carolina
20 Feb 2023 //
PR NEWSWIRE
Wendy Buckland to Join Emmes as Chief Operating Officer
15 Dec 2022 //
PRNEWSWIRE
Emmes Appoints Ching Tian Chief Innovation Officer
14 Dec 2022 //
CONTRACTPHARMA
Emmes Introduces Dedicated Cell and Gene Therapy Center
08 Dec 2022 //
CONTRACTPHARMA
Emmes Acquires Clinical Edge
30 Sep 2022 //
CONTRACTPHARMA
Full-Service CRO Emmes Acquires Clinical Edge
29 Sep 2022 //
CONTRACTPHARMA
Emmes Supports Landmark mRNA COVID-19 Vaccine Trial in Sub-Saharan Africa
16 May 2022 //
PRNEWSWIRE
Emmes Acquires Casimir, Its Fourth Major Acquisition
10 Mar 2022 //
PRNEWSWIRE
Emmes supports new collaboration to advance COVID-19 research for children
04 Feb 2022 //
PHARMAFILE
Emmes and MedGenome Launch Genomics Strategic Partnership
15 Nov 2021 //
PRNEWSWIRE
Emmes Acquires UK-Based Orphan Reach
11 May 2021 //
PRNEWSWIRE